Bon Natural Life Ltd. Files 20-F/A Amendment
Ticker: BON · Form: 20-F/A · Filed: Oct 11, 2024 · CIK: 1816815
Sentiment: neutral
Topics: amendment, financial-reporting, sec-filing
TL;DR
Bon Natural Life filed an update to its 2022 financials on 10/11/24.
AI Summary
Bon Natural Life Ltd. filed an amendment (20-F/A) on October 11, 2024, for its fiscal year ending September 30, 2022. The filing provides updated financial information and disclosures for the company, which operates in the medicinal chemicals and botanical products sector.
Why It Matters
This amendment provides updated financial reporting and disclosures for Bon Natural Life Ltd., which is crucial for investors and stakeholders to assess the company's financial health and operational status.
Risk Assessment
Risk Level: medium — The filing is an amendment to a previous report, indicating potential for revised information or corrections, which can introduce uncertainty.
Key Numbers
- 2022-09-30 — Fiscal Year End (The period for which the financial information in the amendment pertains.)
- 2024-10-11 — Filing Date (The date the amendment was submitted to the SEC.)
Key Players & Entities
- Bon Natural Life Ltd (company) — Filer of the 20-F/A amendment
- 0001493152-24-040806 (document_id) — Accession number for the filing
- 20220930 (date) — Conformed period of report
- 20241011 (date) — Filing date
- 0001816815 (cik) — Central Index Key for Bon Natural Life Ltd
FAQ
What specific financial information was amended in this 20-F/A filing?
The provided text does not detail the specific financial information amended, only that it is an amendment to the 20-F for the period ending September 30, 2022.
What is the primary business of Bon Natural Life Ltd?
Bon Natural Life Ltd. operates in the sector of Medicinal Chemicals & Botanical Products, as indicated by its Standard Industrial Classification code [2833].
When was the original 20-F filing for the period ending September 30, 2022, likely filed?
While the amendment was filed on October 11, 2024, the original 20-F for the fiscal year ending September 30, 2022, would have been filed sometime after that date, typically within a few months.
What is the company's principal executive office address?
The company's business and mailing address is Room 601, Block C, Gazelle Valley, No.69 Jinye Road, High-Tech Zone, Xian, Shaanxi, China, ZIP 710076.
What is the SEC file number for Bon Natural Life Ltd?
The SEC file number for Bon Natural Life Ltd. is 001-40517.
Filing Stats: 4,632 words · 19 min read · ~15 pages · Grade level 12.2 · Accepted 2024-10-10 21:03:18
Key Financial Figures
- $0.0001 — nge On Which Registered Common Stock, $0.0001 par value BON NASDAQ Capital Marke
- $ — sidiary incorporated in Hong Kong. "US$," "U.S. dollars," "$," or "dollars" are
- $9 million — e been as follows: 1) On June 29, 2021, $9 million was transferred from Bon Natural Life t
- $1 million — sidiary in the PRC. 2) On July 9, 2021, $1 million was transferred from Bon Natural Life t
- $630,000 — in August 2021. 3) On January 17, 2023, $630,000 was transferred from Bon Natural Life t
Filing Documents
- form20-fa.htm (20-F/A) — 3438KB
- ex31-1.htm (EX-31.1) — 18KB
- ex31-2.htm (EX-31.2) — 18KB
- ex32-1.htm (EX-32.1) — 7KB
- ex32-2.htm (EX-32.2) — 7KB
- form20-f_001.jpg (GRAPHIC) — 67KB
- form20-f_002.jpg (GRAPHIC) — 31KB
- form20-f_003.jpg (GRAPHIC) — 25KB
- form20-f_004.jpg (GRAPHIC) — 54KB
- form20-f_005.jpg (GRAPHIC) — 3KB
- 0001493152-24-040806.txt ( ) — 13163KB
- bon-20220930.xsd (EX-101.SCH) — 80KB
- bon-20220930_cal.xml (EX-101.CAL) — 109KB
- bon-20220930_def.xml (EX-101.DEF) — 382KB
- bon-20220930_lab.xml (EX-101.LAB) — 581KB
- bon-20220930_pre.xml (EX-101.PRE) — 511KB
- form20-fa_htm.xml (XML) — 1925KB
Selected Financial Data
Selected Financial Data 5 B. Capitalization and Indebtedness 6 C. Reasons for the Offer and Use of Proceeds 6 D.
Risk Factors
Risk Factors 6 ITEM 4. INFORMATION ON THE COMPANY 31 A. History and Development of the Company 31 B. Business Overview 36 C. Organizational Structure 60 D. Property, Plants and Equipment 61 ITEM 4A. UNRESOLVED STAFF COMMENTS 62 ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS 62 A. Operating Results 62 B. Liquidity and Capital Resources 76 C. Research and Development, Patents and Licenses, Etc. 78 D. Trend Information 78 E. Off Balance Sheet Arrangements 79 F. Tabular Disclosure of Contractual Obligations 79 G. Safe Harbor 83 ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES 83 A. Directors and Senior Management 83 B. Compensation 86 C. Board Practices 87 D. Employees 89 E. Share Ownership 89 ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS 90 A. Major Shareholders 90 B. Related Party Transactions 90 C. Interests of Experts and Counsel 91 ITEM 8. FINANCIAL INFORMATION 91 A. Consolidated Statements and Other Financial Information 91 B. Significant Changes 92 ITEM 9. THE OFFER AND LISTING 92 A. Offer and Listing Details 92 B. Plan of Distribution 92 C. Markets 92 D. Selling Shareholders 92 E.
Dilution
Dilution 92 F. Expenses of the Issue 92 i ITEM 10. ADDITIONAL INFORMATION 92 A. Share Capital 92 B. Memorandum and Articles of Association 92 C. Material Contracts 95 D. Exchange Controls 95 E. Taxation 97 F. Dividends and Paying Agents 103 G. 103 H. Documents on Display 103 I. Subsidiary Information 103 ITEM 11.
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 103 ITEM 12.
DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES
DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES 104 A. Debt Securities 104 B. Warrants and Rights 104 C. Other Securities 104 D. American Depositary Shares 104 PART II 104 ITEM 13. DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES 104 ITEM 14. MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS 104 ITEM 15.
CONTROLS AND PROCEDURES
CONTROLS AND PROCEDURES 105 A. Disclosure Controls and Procedures 105 B. Management's Annual Report on Internal Control Over Financial Reporting 105 C. Attestation Report of the Registered Public Accounting Firm 105 D. Changes in Internal Controls over Financial Reporting 106 ITEM 16A. AUDIT COMMITTEE FINANCIAL EXPERT 106 ITEM 16B. CODE OF ETHICS 106 ITEM 16C. PRINCIPAL ACCOUNTANT FEES AND SERVICES 106 ITEM 16D. EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES 106 ITEM 16E. PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS 106 ITEM 16F. CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANT 106 ITEM 16G. CORPORATE GOVERNANCE 106 ITEM 16H. MINE SAFETY DISCLOSURE 106 PART III 107 ITEM 17.
FINANCIAL STATEMENTS
FINANCIAL STATEMENTS 107 ii INTRODUCTORY NOTES Use of Certain Defined Terms Except as otherwise indicated by the context and for the purposes of this report only, references in this report to: "Bon Natural Life," "the Company," "we," "us," "our company" or "our" are to Bon Natural Life Limited a Cayman Islands corporation, its subsidiaries and its consolidated affiliated entities. "China" or the "PRC" are to the People's Republic of China, including Hong Kong and Macau, and excluding, for the purposes of this report only, Taiwan. "Operating subsidiaries" or "PRC subsidiaries" are to Xi'an App-Chem Bio(Tech) Co., Ltd., a PRC company, and its subsidiary entities incorporated in the PRC. "Ordinary shares" or "Shares" are to our ordinary shares, par value $0.0001 per share; "RMB," "Renminbi" "Yuan," or "" are to the legal currency of the People's Republic of China; "Tea Essence" are to Tea Essence Limited, our direct wholly owned subsidiary incorporated in Hong Kong. "US$," "U.S. dollars," "$," or "dollars" are to the legal currency of the United States; "WFOEs" is to Xi'an Cell and Molecule Information Technology Limited and Xi'an Youpincui Biotechnology Co., Ltd. "Xi'an App-Chem" are to Xi'an App-Chem Bio(Tech) Co., Ltd., an entity incorporated in the PRC or, depending on the context, Xi'an App-Chem Bio(Tech) Co., Ltd. and its subsidiaries "Xi'an CMIT" are to Xi'an Cell and Molecule Information Technology Limited, one of our Wholly Foreign-Owned Enterprises incorporated in the PRC "Xi'an Youpincui" are to Xi'an Youpincui Biotechnology Co., Ltd., another of our Wholly Foreign-Owned Enterprises incorporated in the PRC Cautionary Note Regarding Forward-Looking Statements In addition to historical information, this report contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. We use words such as "believe," "expect," "anticipate," "project," "target," "plan," "opti